Phase II trial of Gliadel plus 0(6)-benzylguanine (0(6) -BG) for patients with recurrent glioblastoma multiforme.

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Quinn, JA; Vredenburgh, JJ; Rich, JN; Reardon, DA; Desjardins, A; Gururangan, S; Friedman, AH; Lavin, K; Sathornsumetee, S; Threatt, S; Friedman, HS

Published Date

  • June 20, 2006

Published In

Volume / Issue

  • 24 / 18

Start / End Page

  • 74S - 74S

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 0732-183X

Conference Name

  • 42nd Annual Meeting of the American-Society-of-Clinical-Oncology

Conference Location

  • Atlanta, GA

Conference Start Date

  • June 2, 2006

Conference End Date

  • June 6, 2006